Histopathological evaluation of PYGO2 expression in esophageal squamous cell carcinoma

Author:

Khales Sima Ardalan1,kalat Habibeh Rahmani2,Soleymani Sedigheh2,Jafarian Amir Hossein1,Forghanifard Mohammad Mahdi2

Affiliation:

1. Mashhad University of Medical Sciences

2. Islamic Azad University, Damghan Branch

Abstract

Abstract Background: Esophageal squamous cell carcinoma (ESCC) is one of the world's deadliest cancer diseases. Deregulation of developmental signaling pathways such as Wnt/β-catenin is frequently implicated in a wide range of human cancers. The present study was designed to analyze the expression of the Pygopus2 (PYGO2) protein, the main co-activator of the Wnt/β-catenin signaling pathway, in ESCC tissues and evaluate its probable correlation with clinic-pathological features of patients. Materials and Methods: In this study, PYGO2 protein expression was assessed in tumors and margin normal tissues from 50 ESCC patients using immunohistochemistry (IHC) analysis. Results: Significant PYGO2 overexpression was observed in %94 tumor cells. Interestingly, PYGO2 expression was significantly correlated with the depth of tumor invasion (p= 0.021). Considering the significant expression of PYGO2 protein in ESCC cells and its correlation with tumor invasion. Conclusion: This protein may be used as a biomarker for diagnosis of invasive ESCC, as well as a putative therapeutic target to inhibit ESCC invasiveness.

Publisher

Research Square Platform LLC

Reference25 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;Cancer J Clin,2021

2. Epidemiologic risk factors for esophageal cancer development;Mao W-M;Asian Pac J Cancer Prev,2011

3. Esophageal cancer in Northeastern Iran: a review;Kamangar F;Arch Iran Med,2007

4. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities;Napier KJ;World J Gastrointest Oncol,2014

5. PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts;Sheng Y;Oncotarget,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3